Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Split-dose versus single-dose polyethylene glycol for colonoscopy preparation
IRCT20180103038196N6Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Aug 2018
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of macrogol (2 arms), sponsored by Golestan University of Medical Sciences. Primary endpoint: Quality of colon preparation for colonoscopy. Started Aug 2018; status: completed.
02
Drugs
macrogol
Beyond the preview
Go deeper on IRCT20180103038196N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180103038196N6.